By Colin Kellaher

Bristol-Myers Squibb Co. (BMY) on Monday said Murdo Gordon, executive vice president and chief commercial officer, resigned effective Aug. 3 to pursue another opportunity.

The New York biopharmaceutical company said it will announce a new chief commercial officer at a later date.

Mr. Gordon joined Bristol-Myers Squibb in 1989 and has been chief commercial officer since June 2016, responsible for all sales and marketing activities, as well as customer operations, access and pricing, according to the company's website.

Mr. Gordon received total compensation of about $5.4 million last year, according to a filing with the Securities and Exchange Commission.

Write to Colin Kellaher at colin.kellaher@wsj.com

(END) Dow Jones Newswires

July 23, 2018 09:01 ET (13:01 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Bristol Myers Squibb Charts.
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Bristol Myers Squibb Charts.